scaffolene CL100 Bioresorbable Collagen Matrix (K192346) - FDA 510(k) Clearance

K192346 is an FDA 510(k) clearance for the scaffolene CL100 Bioresorbable Collagen Matrix. Classified as Wound Dressing With Animal-derived Material(s) (product code KGN).

Submitted by Freudenberg Technology Innovation SE & Co. KG (Weinheim, DE). The FDA issued a Cleared decision on February 28, 2020 after a review of 183 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Freudenberg Technology Innovation SE & Co. KG devices